Finance

Beta
Lists
ACB:TSE
Aurora Cannabis Inc
CA$4.22
+1.69%
(+0.070) 1D
Jun 19, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for ACB...
Open
CA$4.14
High
CA$4.22
Low
CA$4.14
Mkt. cap
239.31M
Avg. vol.
410.19K
Volume
98.20K
52-wk high
CA$9.33
52-wk low
CA$3.77
EPS
-CA$0.78
Beta
0.38
Shares outstanding
61.94M
No. of employees
1K
Open
CA$4.14
High
CA$4.22
Low
CA$4.14
Mkt. cap
239.31M
Avg. vol.
410.19K
Volume
98.20K
52-wk high
CA$9.33
52-wk low
CA$3.77
EPS
-CA$0.78
Beta
0.38
Shares outstanding
61.94M
No. of employees
1K
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ACB in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACB in the last 3 months.
Highest
Current $4.22
$5.65 (+33.95%)
Average
$4.59 (+8.77%)
Lowest
$3.53 (-16.28%)
News stories
From sources across the web
Profile
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB. After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO. Wikipedia
About Aurora Cannabis Inc
CEOMiguel Martin
Employees1.03K
FoundedDec 21, 2006
Headquarters-
SectorPharmaceutical industry
Websiteauroramj.com
Last report
Jun 11, 2026
Fiscal period
Q4 2026
EPS / Est. (CAD)
- / -CA$0.50
Revenue / Est. (CAD)
38.01M / 75.42M
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
98.02M
90.37M
94.19M
38.01M
Cost of goods sold
70.07M
58.08M
47.57M
8.22M
Cost of revenue
70.07M
58.08M
47.57M
8.22M
Research and development expenses
829.00K
904.00K
1.30M
986.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.44M
42.11M
41.06M
41.56M
Operating expense
48.17M
50.88M
44.44M
39.82M
Total operating expenses
118.24M
108.96M
92.01M
48.04M
Operating income
-20.22M
-18.59M
2.18M
-10.03M
Other non operating income
584.00K
886.00K
-703.00K
-47.00K
EBT including unusual items
-19.38M
-46.98M
-1.58M
11.41M
EBT excluding unusual items
-19.38M
-14.55M
-1.58M
-5.05M
Income tax expense
-3.00K
6.19M
164.00K
-4.26M
Effective tax rate
0.02%
-13.18%
-10.39%
-37.29%
Other operating expenses
-
-
-
-
Net income
-15.21M
-51.47M
1.82M
-71.10M
Net profit margin
-15.52%
-56.96%
1.93%
-187.04%
Earnings per share
-
-
-
-
Interest and investment income
1.97M
1.85M
991.00K
5.33M
Interest expense
-1.78M
-2.22M
-2.11M
-
Net interest expenses
193.00K
-374.00K
-1.12M
5.33M
Depreciation and amortization charges
1.71M
2.90M
2.62M
-3.42M
EBITDA
-14.04M
-12.36M
8.58M
-6.60M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer